These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37207469)

  • 1. Design, synthesis and biological evaluation of novel lipophilic 2, 5-disubstituted tetrazole analogues of muramyl dipeptide as NOD2 agonists.
    Mhamane TB; Sambyal S; Vemireddy S; Paturu RSR; Katragadda SB; Syed S; Khan A; Halmuthur M SK
    Bioorg Med Chem; 2023 Jun; 88-89():117296. PubMed ID: 37207469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity.
    Cheng WC; You TY; Teo ZZ; Sayyad AA; Maharana J; Guo CW; Liang PH; Lin CS; Meng FC
    Chem Asian J; 2020 Nov; 15(22):3836-3844. PubMed ID: 32975372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel 2-azido muramyl dipeptide as NOD2 agonistic adjuvants.
    Reddy PRS; Sambyal S; Mhamane TB; Sravanthi V; Shafi S; Khan IA; Sampath Kumar HM
    Bioorg Med Chem; 2022 Jul; 66():116781. PubMed ID: 35569249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of biologically active biotinylated muramyl dipeptides.
    Grimes CL; Podolsky DK; O'Shea EK
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6061-3. PubMed ID: 20822907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.
    Coulombe F; Fiola S; Akira S; Cormier Y; Gosselin J
    PLoS One; 2012; 7(5):e36734. PubMed ID: 22590599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A closer look at ligand specificity for cellular activation of NOD2 with synthetic muramyl dipeptide analogues.
    Adamson C; Liang Y; Feng S; Ng AWR; Qiao Y
    Chem Commun (Camb); 2024 Feb; 60(16):2212-2215. PubMed ID: 38305731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane targeting enhances muramyl dipeptide binding to NOD2 and Arf6-GTPase in mammalian cells.
    Hespen CW; Zhao X; Hang HC
    Chem Commun (Camb); 2022 Jun; 58(46):6598-6601. PubMed ID: 35584401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
    Hedl M; Abraham C
    J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipophilic Muramyl Dipeptide-Antigen Conjugates as Immunostimulating Agents.
    Willems MM; Zom GG; Meeuwenoord N; Khan S; Ossendorp F; Overkleeft HS; van der Marel GA; Filippov DV; Codée JD
    ChemMedChem; 2016 Jan; 11(2):190-8. PubMed ID: 26059481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2 ligation subverts IFN-alpha production by liver plasmacytoid dendritic cells and inhibits their T cell allostimulatory activity via B7-H1 up-regulation.
    Castellaneta A; Sumpter TL; Chen L; Tokita D; Thomson AW
    J Immunol; 2009 Dec; 183(11):6922-32. PubMed ID: 19890047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Immunological Evaluation of Mannosylated Desmuramyl Dipeptides Modified by Lipophilic Triazole Substituents.
    Petrović Peroković V; Car Ž; Bušljeta M; Mihelec D; Paurević M; Ivanković S; Stojković R; Ribić R
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties.
    Gobec M; Tomašič T; Štimac A; Frkanec R; Trontelj J; Anderluh M; Mlinarič-Raščan I; Jakopin Ž
    J Med Chem; 2018 Apr; 61(7):2707-2724. PubMed ID: 29543461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic NOD2 agonist, muramyl dipeptide (MDP)-Lys (L18) and IFN-β synergistically induce dendritic cell maturation with augmented IL-12 production and suppress melanoma growth.
    Fujimura T; Yamasaki K; Hidaka T; Ito Y; Aiba S
    J Dermatol Sci; 2011 May; 62(2):107-15. PubMed ID: 21411292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonizing NOD2 Signaling with Conjugates of Paclitaxel and Muramyl Dipeptide Derivatives Sensitizes Paclitaxel Therapy and Significantly Prevents Tumor Metastasis.
    Dong Y; Wang S; Wang C; Li Z; Ma Y; Liu G
    J Med Chem; 2017 Feb; 60(3):1219-1224. PubMed ID: 28075581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of biotinylated muramyl tripeptides with NOD2-stimulating activity.
    Gisch N; Buske B; Heine H; Lindner B; Zähringer U
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3362-6. PubMed ID: 21530249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distinct response of gammadelta T cells to the Nod2 agonist muramyl dipeptide.
    Kerns HM; Jutila MA; Hedges JF
    Cell Immunol; 2009; 257(1-2):38-43. PubMed ID: 19306993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17β-Estradiol and progesterone decrease MDP induced NOD2 expression in bovine mammary epithelial cells.
    Xu DD; Wang G; He XJ; Wang JF; Yang B; Sun ZP; Sun DB; He QY; Zhang X; Wu R
    Vet Immunol Immunopathol; 2017 Jun; 188():59-64. PubMed ID: 28615128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model.
    Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB
    Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.